ResMed | RMD - Operating Expenses



ResMed reported $892.93M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Ansell USD 358.55M 386.85M Jun/2024
AtriCure USD 142.33M 12.76M Jun/2025
Baxter International USD 2.54B 29M Jun/2025
Cochlear AUD 897.2M 19.8M Dec/2024
Cooper Companies USD 884.6M 67.1M Jul/2025
CSL USD 5.72B 173M Dec/2024
Dexcom USD 944.5M 42.2M Jun/2025
Edwards Lifesciences USD 1.1B 83.4M Jun/2025
Fisher Paykel Healthcare NZD 389.15M 343.95M Mar/2025
Globus Medical USD 1.62B 1.12B Jun/2025
Haemonetics USD 250.55M 29.34M Jun/2025
Hologic USD 762.9M 249.4M Jun/2025
Idexx Laboratories USD 736.41M 54.52M Jun/2025
Insulet USD 528M 8.3M Jun/2025
Integra LifeSciences USD 416.91M 18.3M Jun/2025
Intuitive Surgical USD 1.69B 17.8M Jun/2025
Masimo USD 306.4M 12.4M Jun/2025
Medtronic USD 7.06B 430M Jul/2025
Philips EUR 3.85B 93M Jun/2025
Ramsay Health Care AUD 8.35B 258.6M Dec/2024
ResMed USD 892.93M 27.46M Jun/2025
Sigma Healthcare AUD 1.87B 192.57M Jul/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Steris USD 1.07B 195.04M Jun/2025
Teleflex USD 603.41M 33.06M Jun/2025
Thermo Fisher Scientific USD 8.94B 291M Jun/2025